Classification of Rare Missense Substitutions, Using Risk Surfaces, With Genetic- and Molecular-Epidemiology Applications

被引:182
作者
Tavtigian, Sean V. [1 ]
Byrnes, Graham B. [1 ]
Goldgar, David E. [2 ]
Thomas, Alun [3 ]
机构
[1] Int Agcy Res Canc, F-69372 Lyon, France
[2] Univ Utah, Sch Med, Dept Dermatol, Salt Lake City, UT USA
[3] Univ Utah, Sch Med, Dept Biomed Informat, Salt Lake City, UT USA
基金
加拿大健康研究院;
关键词
BRCA1; BRCA2; Align-GVGD; unclassified variant; missense substitution; protein multiple sequence alignment;
D O I
10.1002/humu.20896
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Many individually rare missense substitutions are encountered during deep resequencing of candidate susceptibility genes and clinical mutation screening of known susceptibility genes. BRCA1 and BRCA2 are among the most resequenced of all genes, and clinical mutation screening of these genes provides an extensive data set for analysis of rare missense substitutions. Align-GVGD is a mathematically simple missense substitution analysis algorithm, based on the Grantham difference, which has already contributed to classification of missense substitutions in BRCA1, BRCA2, and CHEK2. However, the distribution of genetic risk as a function of Align-GVGD's output variables Grantham variation (GV) and Grantham deviation (GD) has not been well characterized. Here, we used data from the Myriad Genetic Laboratories database of nearly 70,000 full-sequence tests plus two risk estimates, one approximating the odds ratio and the other reflecting strength of selection, to display the distribution of risk in the GV-GD plane as a series of surfaces. We abstracted contours from the surfaces and used the contours to define a sequence of missense substitution grades ordered from greatest risk to least risk. The grades were validated internally using a third, personal and family history-based, measure of risk. The Align-GVGD grades defined here are applicable to both the genetic epidemiology problem of classifying rare missense substitutions observed in known susceptibility genes and the molecular epidemiology problem of analyzing rare missense substitutions observed during case-control mutation screening studies of candidate susceptibility genes. Hum Mutat 29(11), 1342-1354, 2008. (C) 2008 Wiley-Liss, Inc.
引用
收藏
页码:1342 / 1354
页数:13
相关论文
共 31 条
  • [1] Analysis of missense variation in human BRCA1 in the context of interspecific sequence variation
    Abkevich, V
    Zharkikh, A
    Deffenbaugh, AM
    Frank, D
    Chen, Y
    Shattuck, D
    Skolnick, MH
    Gutin, A
    Tavtigian, SV
    [J]. JOURNAL OF MEDICAL GENETICS, 2004, 41 (07) : 492 - 507
  • [2] Use of estimated evolutionary strength at the codon level improves the prediction of disease-related protein mutations in humans
    Capriotti, Emidio
    Arbiza, Leonardo
    Casadio, Rita
    Dopazo, Joaquin
    Dopazo, Hernan
    Marti-Renom, Marc A.
    [J]. HUMAN MUTATION, 2008, 29 (01) : 198 - 204
  • [3] Interpreting missense variants:: Comparing computational methods in human disease genes CDKN2A, MLH1, MSH2, MECP2, and tyrosinase (TYR)
    Chan, Philip A.
    Duraisamy, Sekhar
    Miller, Peter J.
    Newell, Joan A.
    McBride, Carole
    Bond, Jeffrey P.
    Raevaara, Tiina
    Ollila, Saara
    Nystrom, Minna
    Grimm, Andrew J.
    Christodoulou, John
    Oetting, William S.
    Greenblatt, Marc S.
    [J]. HUMAN MUTATION, 2007, 28 (07) : 683 - 693
  • [4] Genetic and histopathologic evaluation of BRCA1 and BRCA2 DNA sequence variants of unknown clinical significance
    Chenevix-Trench, G
    Healey, S
    Lakhani, S
    Waring, P
    Cummings, M
    Brinkworth, R
    Deffenbaugh, AM
    Burbidge, LA
    Pruss, D
    Judkins, T
    Scholl, T
    Bekessy, A
    Marsh, A
    Lovelock, P
    Wong, M
    Tesoriero, A
    Renard, H
    Southey, M
    Hopper, JL
    Yannoukakos, K
    Brown, M
    Easton, D
    Tavtigian, SV
    Goldgars, D
    Spurdle, AB
    [J]. CANCER RESEARCH, 2006, 66 (04) : 2019 - 2027
  • [5] Multiple rare Alleles contribute to low plasma levels of HDL cholesterol
    Cohen, JC
    Kiss, RS
    Pertsemlidis, A
    Marcel, YL
    McPherson, R
    Hobbs, HH
    [J]. SCIENCE, 2004, 305 (5685) : 869 - 872
  • [6] A systematic genetic assessment of 1,433 sequence variants of unknown clinical significance in the BRCA1 and BRCA2 breast cancer-predisposition genes
    Easton, Douglas F.
    Deffenbaugh, Amie M.
    Pruss, Dmitry
    Frye, Cynthia
    Wenstrup, Richard J.
    Allen-Brady, Kristina
    Tavtigian, Sean V.
    Monteiro, Alvaro N. A.
    Iversen, Edwin S.
    Couch, Fergus J.
    Goldgar, David E.
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 2007, 81 (05) : 873 - 883
  • [7] Sequence-based prediction of pathological mutations
    Ferrer-Costa, C
    Orozco, M
    de la Cruz, X
    [J]. PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 2004, 57 (04) : 811 - 819
  • [8] AN IMPROVED METHOD FOR DETERMINING CODON VARIABILITY IN A GENE AND ITS APPLICATION TO RATE OF FIXATION OF MUTATIONS IN EVOLUTION
    FITCH, WM
    MARKOWITZ, E
    [J]. BIOCHEMICAL GENETICS, 1970, 4 (05) : 579 - +
  • [9] Genetic Evidence and Integration of Various Data Sources for Classifying Uncertain Variants Into a Single Model
    Goldgar, David E.
    Easton, Douglas E.
    Byrnes, Graham B.
    Spurdle, Amanda B.
    Iversen, Edwin S.
    Greenblatt, Marc S.
    [J]. HUMAN MUTATION, 2008, 29 (11) : 1265 - 1272
  • [10] Integrated evaluation of DNA sequence variants of unknown clinical significance:: Application to BRCA1 and BRCA2
    Goldgar, DE
    Easton, DF
    Deffenbaugh, AM
    Monteiro, ANA
    Tavtigian, SV
    Couch, FJ
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 2004, 75 (04) : 535 - 544